News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Astellas Pharma Inc.: Won't Raise OSI Pharmaceuticals, Inc. (OSIP) Bid on FDA Move Alone


4/19/2010 6:28:28 AM

Reuters -- Astellas Pharma (4503.T), Japan's No.2 drugmaker, said on Monday it has no plan to lift its bid for OSI Pharmaceuticals (OSIP.O) despite U.S. regulators approving wider use of OSI's cancer pill Tarceva.

Read at Reuters
Read at Bloomberg


comments powered by Disqus
Reuters
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES